News
  • About Us
  • Test serviecs
  • Regulations
  • R & D Service
  • News
  • Contact Us
  • Congratulations to Rainbowlabs for passing the CNAS inspecti

    2015-06-16 15:26:42
    Congratulations to Rainbowlabs for passing the CNAS inspecti
    A good news came that Rainbow Labs passed the site assessment of China National Accreditation Service for Conformity Assessment (CNAS) on November 9, 2014. At present, CNAS is the unique and most authoritative laboratory accreditation certification body. Being approved by CNAS, proves that our level and capacity are up to international standard, product inspection result reliable. The certificate or report issued by us, will be recognized by 56 countries in a mutual recognition system.

    Since then, Rainbow Labs becomes a laboratory which is approved and qualified by the US FDA, Health Canada and CNAS China at the same time. We will constantly make intensified effort on international registration and mutual recognition, unswervingly adhere to the strategy of quality innovation combined with the international high-end market access.
  • comments list

    [DarrylMep  2023-08-25 16:29]  mexico pharmacy accutane
    [MichaelWen  2023-08-25 15:01]  0.75 mg albuterol
    [ElwoodDwese  2023-08-25 13:35]  acyclovir cream over the counter in mexico
    [Hectoredifs  2023-08-25 12:23]  Good posts. Appreciate it. essay writing service dubai dissertation consulting dissertation coach cost phd.research paid dissertation who is the best essay writing service daddy-daughter roleplay convincing daddy to not do my homework can i pay someone to do my coding homework i want someone to do my homework i don t want to do my homework in spanish
    [Richardreexy  2023-08-25 10:09]  disulfiram 200mg tablets
    Total 33572/33687 Pages Frist Prev Prev10  33571  33572  33573   33574   33575   33576   33577   33578   33579   33580  Next10 Next Last

    I want to comment

    content*
    Your name
    Verify code* 
  • Go Top
Shijiazhuang Rainbowlabs pharmaceutical Technology Co. Ltd  Copyright